Abstract
RNA interference (RNAi) is an evolutionarily conserved phenomenon of double-stranded (ds)RNA-mediated mRNA degradation that leads to the posttranscriptional silencing of the corresponding gene. First reports on RNAi emerged in 1998, and since then, it has become one of the most fascinating fields of molecular biology. RNAi has provided important insights about the diversity of RNA molecules and their implication in many biological processes such as the regulation of developmental genes in eukaryotic organisms. Furthermore, RNAi has rapidly developed into a powerful instrument with a great potential for functional genomics and therapeutic applications by silencing normal and disease-related gene functions. To date, the use of RNAi for genetic-based therapies is widely studied, especially in viral infections, cancers, and inherited genetic disorders. Despite the many unanswered questions on how this technology can be efficiently applied to humans, the development of novel approaches, such as vaccines or novel delivery agents, is certainly one of the major goals in RNAi research.
Chapter PDF
Similar content being viewed by others
References
Fire A, Xu SQ, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391(6669):806–811.
Guo S, Kemphues KJ. Par-1, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed. Cell 1995; 81(4):611–620.
Timmons L, Fire A. Specific interference by ingested dsRNA. Nature 1998; 395(6705):854.
Schmitz K, Schepers U. Silencio: RNA interference, the tool of the new millennium. Biol Chem 2004; in press.
Montgomery MK, Xu SQ, Fire A. RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans. Proc Natl Acad Sci USA 1998; 95(26):15,502–15,507.
Montgomery MK, Fire A. Double-stranded RNA as a mediator in sequence specific genetic silencing and co-suppression. Trends Genet 1998; 14(7):255–258.
Timmons L, Tabara H, Mello CC, Fire AZ. Inducible systemic RNA silencing in Caenorhabditis elegans. Mol Biol Cell 2003; 14(7):2972–2983.
Winston WM, Molodowitch C, Hunter CP. Systemic RNAi in C. elegans requires the putative transmembrane protein SID-1. Science 2002; 295(5564):2456–2459.
Tabara H, Grishok A, Mello CC. RNAi in C. elegans: soaking in the genome sequence. Science 1998; 282(5388):430–431.
Voinnet O. RNA silencing as a plant immune system against viruses. Trends Genet 2001; 17(8): 449–459.
Ruiz MT, Voinnet O, Baulcombe DC. Initiation and maintenance of virus-induced gene silencing. Plant Cell 1998; 10(6):937–946.
Ketting RF, Haverkamp TH, van Luenen HG, Plasterk RH. Mut-7 of C. elegans, required for transposon silencing and RNA interference, is a homolog of Werner syndrome helicase and RNaseD. Cell 1999; 99(2): 133–141.
Tabara H, Sarkissian M, Kelly WG, et al. The rde-1 gene, RNA interference, and transposon silencing in C. elegans. Cell 1999; 99(2):123–132.
Plasterk RHA. RNA silencing: the genome’s immune system. Science 2002; 296(5571): 1263–1265.
Domeier ME, Morse DP, Knight SW, Portereiko M, Bass BL, Mango SE. A link between RNA interference and nonsense-mediated decay in Caenorhabditis elegans. Science 2000; 289(5486):1928–1930.
McManus MT, Petersen CP, Haines BB, Chen J, Sharp PA. Gene silencing using micro-RNA designed hairpins. RNA 2002; 8(6):842–850.
Mourrain P, Beclin C, Elmayan T, et al. Arabidopsis SGS2 and SGS3 genes are required for posttranscriptional gene silencing and natural virus resistance. Cell 2000; 101(5):533–542.
Cogoni C, Macino G. Gene silencing in Neurospora crassa requires a protein homologous to RNA-dependent RNA polymerase. Nature 1999; 399(6732):166–169.
Cogoni C, Macino G. Isolation of quelling defective (QDE) mutants impaired in posttranscriptional transgene-induced gene silencing in neurospora crassa. Proc Natl Acad Sci USA 1997; 94(19):10,233–10,238.
Smardon A, Spoerke JM, Stacey SC, Klein ME, Mackin N, Maine EM. EGO-1 is related to RNA-directed RNA polymerase and functions in germ-line development and RNA interference in C. elegans. Curr Biol 2000; 10(4):169–178.
Qiao L, Lissemore JL, Shu P, Smardon A, Gelber MB, Maine EM. Enhancers of glp-1, a gene required for cell-signaling in Caenorhabditis elegans, define a set of genes required for germline development. Genetics 1995; 141(2):551–569.
Hamilton AJ, Baulcombe DC. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 1999; 286(5441):950–952.
Zamore PD, Tuschl T, Sharp PA, Bartel DP. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 2000; 101(1):25–33.
Yang D, Lu H, Erickson JW. Evidence that processed small dsRNAs may mediate sequence-specific mRNA degradation during RNAi in Drosophila embryos. Curr Biol 2000; 10(19):1191–1200.
Wu H, Xu H, Miraglia LJ, Crooke ST. Human RNase III is a 160-kDa protein involved in preribosomal RNA processing. J Biol Chem 2000; 275(47):36,957–36,965.
Filippov V, Solovyev V, Filippova M, Gill SS. A novel type of RNase III family proteins in eukaryotes. Gene 2000; 245(1):213–221.
Bernstein E, Caudy AA, Hammond SM, Hannon GJ. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001; 409(6818):363–366.
Rotondo G, Frendewey D. Purification and characterization of the Pac1 ribonuclease of schizosaccharomyces pombe. Nucleic Acids Res 1996; 24(12):2377–2386.
Mian IS. Comparative sequence analysis of ribonucleases Hii, Iii, Ii Ph and D. Nucleic Acids Res 1997; 25(16):3187–3195.
Aravind L, Koonin EV. A natural classification of ribonucleases. Methods Enzymol 2001; 341:3–28.
Cerutti L, Mian N, Bateman A. Domains in gene silencing and cell differentiation proteins: the novel PAZ domain and redefinition of the Piwi domain. Trends Biochem Sci 2000; 25(10):481–482.
Ketting RF, Fischer SEJ, Bernstein E, Sijen T, Hannon GJ, Plasterk RHA. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev 2001; 15(20): 2654–2659.
Schauer SE, Jacobsen SE, Meinke DW, Ray A. DICER-LIKE1: blind men and elephants in Arabidopsis development. Trends Plant Sci 2002; 7(11):487–491.
Ketting RF, Plasterk RHA. A genetic link between co-suppression and RNA interference in C. elegans. Nature 2000; 404(6775):296–298.
Lau NC, Lim LP, Weinstein EG, Bartel DP. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001; 294(5543):858–862.
Lee RC, Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001; 294(5543):862–864.
Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr Biol 2002; 12(9):735–739.
Lee Y, Jeon K, Lee JT, Kim S, Kim VN. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 2002; 21(17): 4663–4670.
Reinhart BJ, Weinstein EG, Rhoades MW, Bartel B, Bartel DP. MicroRNAs in plants. Genes Dev 2002; 16(13):1616–1626.
Lagos-Quintana M, Rauhut R, Meyer J, Borkhardt A, Tuschl T. New microRNAs from mouse and human. RNA 2003; 9(2):175–179.
Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W, Tuschl T. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J 2001; 20(23):6877–6888.
Blaszczyk J, Tropea JE, Bubunenko M, et al. Crystallographic and modeling studies of RNase III suggest a mechanism for double-stranded RNA cleavage. Structure 2001; 9(12):1225–1236.
Hannon GJ. RNA interference. Nature 2002; 418(6894):244–251.
Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, Zamore PD. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 2001; 293(5531):834–838.
Myers JW, Jones JT, Meyer T, Ferrell JE Jr. Recombinant Dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing. Nature Biotechnol 2003; 21(3):324–328.
Provost P, Dishart D, Doucet J, Frendewey D, Samuelsson B, Radmark O. Ribonuclease activity and RNA binding of recombinant human Dicer. EMBO J 2002; 21(21):5864–5874.
Zhang H, Kolb FA, Brondani V, Billy E, Filipowicz W. Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP. EMBO J 2002; 21(21):5875–5885.
Martinez J, Patkaniowska A, Urlaub H, Luhrmann R, Tuschl T. Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 2002; 110(5):563–574.
Nykänen A, Haley B, Zamore PD. ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell 2001; 107(3):309–321.
Hammond SM, Boettcher S, Caudy AA, Kobayashi R, Hannon GJ. Argonaute2, a link between genetic and biochemical analyses of RNAi. Science 2001; 293(5532):1146–1150.
Liu Q, Rand TA, Kalidas S, et al. R2D2, a bridge between the initiation and effector steps of the Drosophila RNAi pathway. Science 2003; 301(5641):1921–1925.
Hammond SM, Bernstein E, Beach D, Hannon GJ. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 2000; 404(6775):293–296.
Carmell MA, Xuan Z, Zhang MQ, Hannon GJ. The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis. Genes Dev 2002; 16(21):2733–2742.
Schwarz DS, Hutvagner G, Haley B, Zamore PD. Evidence that siRNAs function as guides, not primers, in the Drosophila and human RNAi pathways. Mol Cell 2002; 10(3):537–548.
Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD. Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003; 115(2):199–208.
Khvorova A, Reynolds A, Jayasena SD. Functional siRNAs and miRNAs exhibit strand bias. Cell 2003; 115(2):209–216.
Jackson AL, Bartz SR, Schelter J, et al. Expression profiling reveals off-target gene regulation by RNAi. Nature Biotechnol 2003; 21(6):635–637.
Song JJ, Liu J, Tolia NH, et al. The crystal structure of the Argonaute2 PAZ domain reveals an RNA binding motif in RNAi effector complexes. Nature Struct Biol 2003; 10(12):1026–1032.
Yan KS, Yan S, Farooq A, Han A, Zeng L, Zhou MM. Structure and conserved RNA binding of the PAZ domain. Nature 2003; 26:468–474.
Lingel A, Simon B, Izaurralde E, Sattler M. Structure and nucleic-acid binding of the Drosophila Argonaute 2 PAZ domain. Nature 2003; 426:465–469.
Ponting CP. Evidence for PDZ domains in bacteria, yeast, and plants. Protein Sci 1997; 6(2): 464–468.
Callebaut I, Mornon JP. The human EBNA-2 coactivator p100: multidomain organization and relationship to the staphylococcal nuclease fold and to the tudor protein involved in Drosophila melanogaster development. Biochem J 1997; 321(Pt 1):125–132.
Caudy AA, Ketting RF, Hammond SM, et al. A micrococcal nuclease homologue in RNAi effector complexes. Nature 2003; 425(6956):411–414.
Arenz C, Schepers U. RNA interference: from an ancient mechanism to a state of the art therapeutic application? Naturwissenschaften 2003; 90(8):345–359.
Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science 2001; 291(5507): 1304–1351.
Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409(6822):860–921.
Nagy A, Perrimon N, Sandmeyer S, Plasterk R. Tailoring the genome: the power of genetic approaches. Nature Genet 2003; 33(Suppl):276–284.
Rajewsky K, Gu H, Kuhn R, et al. Conditional gene targeting. J Clin Invest 1996; 98(3): 600–603.
Nagy A. Cre recombinase: the universal reagent for genome tailoring [review]. Genesis 2000; 26(2): 99–109.
Famulok M. Oligonucleotide aptamers that recognize small molecules. Curr Opin Struct Biol 1999; 9(3):324–329.
Sullenger BA, Gallardo HF, Ungers GE, Gilboa E. Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 1990; 63(3):601–608.
Bosher JM, Labouesse M. RNA interference: genetic wand and genetic watchdog. Nature Cell Biol 2000; 2(2):E31–E36.
Hunter CP. Genetics: a touch of elegance with RNAi. Curr Biol 1999; 9(12):R440–R442.
Feinberg EH, Hunter CP. Transport of dsRNA into cells by the transmembrane protein SID-1. Science 2003; 301(5639):1545–1547.
Kamath RS, Ahringer J. Genome-wide RNAi screening in Caenorhabditis elegans. Methods 2003; 30(4):313–321.
Montgomery MK. The use of double-stranded RNA to knock down specific gene activity. Methods Mol Biol 2004; 260:129–144.
Clemens JC, Worby CA, Simonson-Leff N, et al. Use of double-stranded RNA interference in Drosophila cell lines to dissect signal transduction pathways. Proc Natl Acad Sci USA 2000; 97(12):6499–6503.
Grishok A, Mello CC. RNAi (Nematodes: Caenorhabditis elegans). Adv Genet 2002; 46:339–360.
Grishok A, Tabara H, Mello CC. Genetic requirements for inheritance of RNAi in C. elegans. Science 2000; 287(5462):2494–2497.
Maeda I, Kohara Y, Yamamoto M, Sugimoto A. Large-scale analysis of gene function in Caenorhabditis elegans by high-throughput RNAi. Curr Biol 2001; 11(3):171–176.
Schumacher JM, Golden A, Donovan PJ. AIR-2: an Aurora/Ip11-related protein kinase associated with chromosomes and midbody microtubules is required for polar body extrusion and cytokinesis in Caenorhabditis elegans embryos. J Cell Biol 1998; 143(6):1635–1646.
Chase D, Serafinas C, Ashcroft N, et al. The polo-like kinase PLK-1 is required for nuclear envelope breakdown and the completion of meiosis in Caenorhabditis elegans. Genesis 2000; 26(1):26–41.
Ashrafi K, Chang FY, Watts JL, et al. Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature 2003; 421(6920):268–272.
Fraser AG, Kamath RS, Zipperlen P, Martinez-Campos M, Sohrmann M, Ahringer J. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature 2000; 408(6810): 325–330.
Castillo-Davis CI, Hartl DL. Conservation, relocation and duplication in genome evolution. Trends Genet 2003; 19(11):593–597.
Gonczy P, Echeverri C, Oegema K, et al. Functional genomic analysis of cell division in C. elegans using RNAi of genes on chromosome III. Nature 2000; 408(6810):331–336.
Lee SS, Lee RY, Fraser AG, Kamath RS, Ahringer J, Ruvkun G. A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity. Nature Genet 2003; 33(1):40–48.
Kennerdell JR, Carthew RW. Use of dsRNA-mediated genetic interference to demonstrate that frizzled and frizzled 2 act in the wingless pathway. Cell 1998; 95(7):1017–1026.
Kiger A, Baum B, Jones S, et al. A functional genomic analysis of cell morphology using RNA interference. J Biol 2003; 2(4):27.
Boutros M, Kiger AA, Armknecht S, et al. Genome-wide RNAi analysis of growth and viability in Drosophila cells. Science 2004; 303(5659):832–835.
Somma MP, Fasulo B, Cenci G, Cundari E, Gatti M. Molecular dissection of cytokinesis by RNA interference in Drosophila cultured cells. Mol Biol Cell 2002; 13(7):2448–2460.
Maiato H, Sunkel CE, Earnshaw WC. Dissecting mitosis by RNAi in Drosophila tissue culture cells. Biol Proc Online 2003; 5:153–161.
Goshima G, Vale RD. The roles of microtubule-based motor proteins in mitosis: comprehensive RNAi analysis in the Drosophila S2 cell line. J Cell Biol 2003; 162(6):1003–1016.
Clemens MJ, Elia A. The double-stranded RNA-dependent protein kinase PKR-structure and function [review]. J Interferon Cytokine Res 1997; 17(9):503–524.
Clemens MJ. Pkr—a protein kinase regulated by double-stranded RNA. Int J Biochem Cell Biol 1997; 29(7):945–949.
Wianny F, Zernicka-Goetz M. Specific interference with gene function by double-stranded RNA in early mouse development. Nature Cell Biol 2000; 2(2):70–75.
Billy E, Brondani V, Zhang H, Muller U, Filipowicz W. Specific interference with gene expression induced by long, double-stranded RNA in mouse embryonal teratocarcinoma cell lines. Proc Natl Acad Sci USA 2001; 98(25): 14,428–14,433.
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411(6836):494–498.
Krichevsky AM, Kosik KS. RNAi functions in cultured mammalian neurons. Proc Natl Acad Sci USA 2002; 99(18): 11,926–11,929.
Chiu YL, Rana TM. siRNA function in RNAi: a chemical modification analysis. RNA 2003; 9(9):1034–1048.
Chiu YL, Rana TM. RNAi in human cells: basic structural and functional features of small interfering RNA. Mol Cell 2002; 10(3):549–561.
Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A. Rational siRNA design for RNA interference. Nat Biotechnol 2004; 22:326–330.
Caplen NJ, Parrish S, Imani F, Fire A, Morgan RA. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci USA 2001; 98(17): 9742–9747.
Gitlin L, Andino R. Nucleic acid-based immune system: the antiviral potential of mammalian RNA silencing. J Virol 2003; 77(13):7159–7165.
Martins LM, Iaccarino I, Tenev T, et al. The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J Biol Chem 2002; 277(1):439–444.
Cioca DP, Aoki Y, Kiyosawa K. RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines. Cancer Gene Therapy 2003; 10(2):125–133.
Donze O, Picard D. RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase. Nucleic Acids Res 2002; 30(10):e46.
Weil A, Garcon L, Harper M, Dumenil D, Dautry R, Kress M. Targeting the kinesin Eg5 to monitor siRNA transfection in mammalian cells. Biotechniques 2002; 33(6):1244–1248.
Dunne J, Drescher B, Riehle H, et al. The apparent uptake of fluorescently labeled siRNAs by electroporated cells depends on the fluorochrome. Oligonucleotides 2003; 13(5):375–380.
Walters DK, Jelinek DF. The effectiveness of double-stranded short inhibitory RNAs (siRNAs) may depend on the method of transfection. Antisense Nucleic Acid Drug Dev 2002; 12(6):411–418.
Scherr M, Morgan MA, Eder M. Gene silencing mediated by small interfering RNAs in mammalian cells. Curr Med Chem 2003; 10(3):245–256.
Heidenreich O, Krauter J, Riehle H, et al. AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8; 21)-positive leukemic cells. Blood 2003; 101(8):3157–3163.
Simeoni F, Morris MC, Heitz F, Divita G. Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucleic Acids Res 2003; 31(11):2717–2724.
Prochiantz A. Getting hydrophilic compounds into cells—lessons from homeopeptides (Commentary). Curr Opin Neurobiol 1996; 6(5):629–634.
Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF. In vivo protein transduction: delivery of a biologically active protein into the mouse [comment]. Science 1999; 285(5433):1569–1572.
Schwarze SR, Dowdy SF. In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol Sci 2000; 21(2):45–48.
Derossi D, Joliot AH, Chassaing G, Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem 1994; 269(14):10,444–10,450.
Derossi D, Chassaing G, Prochiantz A. Trojan peptides—the penetratin system for intracellular delivery. Trends Cell Biol 1998; 8(2):84–87.
Schmitz K, Schepers U. Cell penetrating peptides in siRNA delivery. Expert Opin Biol Ther 2004; in press.
Schmitz K, Diallo M, Mundegar R, Schepers U. pepsiRNAs for RNAi in mammals. Submitted.
Berns K, Hijmans EM, Mullenders J, et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 2004; 428(6981):431–437.
Kisielow M, Kleiner S, Nagasawa M, Faisal A, Nagamine Y. Isoform-specific knockdown and expression of adaptor protein ShcA using small interfering RNA. Biochem J 2002; 363(1):1–5.
Czauderna F, Fechtner M, Aygun H, et al. Functional studies of the PI(3)-kinase signalling pathway employing synthetic and expressed siRNA. Nucleic Acids Res 2003; 31(2):670–682.
Xu Z, Williams CJ, Kopf GS, Schultz RM. Maturation-associated increase in IP3 receptor type 1: role in conferring increased IP3 sensitivity and Ca2+ oscillatory behavior in mouse egg. Dev Biol 2003; 254(2): 163–171.
Stucke VM, Sillje HH, Arnaud L, Nigg EA. Human Mps1 kinase is required for the spindle assembly checkpoint but not for centrosome duplication. EMBO J 2002; 21(7):1723–1732.
Ohta T, Essner R, Ryu JH, Palazzo RE, Uetake Y, Kuriyama R. Characterization of Cep135, a novel coiled-coil centrosomal protein involved in microtubule organization in mammalian cells. J Cell Biol 2002; 156(1): 87–99.
Salisbury JL, Suino KM, Busby R, Springett M. Centrin-2 is required for centriole duplication in mammalian cells. Curr Biol 2002; 12(15):1287–1292.
Prasanth KV, Sacco-Bubulya PA, Prasanth SG, Spector DL. Sequential entry of components of the gene expression machinery into daughter nuclei. Mol Biol Cell 2003; 14(3):1043–1057.
Cabot RA, Prather RS. Cleavage stage porcine embryos may have differing developmental requirements for karyopherins alpha2 and alpha3. Mol Reprod Dev 2003; 64(3):292–301.
Kim VN. RNA interference in functional genomics and medicine [review]. J Korean Med Sci 2003; 18(3):309–318.
Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 2002; 16(8):948–958.
Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296(5567):550–553.
Sui G, Soohoo C, El Affar B, Gay F, Shi Y, Forrester WC. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci USA 2002; 99(8):5515–5520.
Miyagishi M, Taira K. U6 promoter driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nature Biotechnol 2002; 20(5):497–500.
Paul CP, Good PD, Winer I, Engelke DR. Effective expression of small interfering RNA in human cells. Nature Biotechnol 2002; 20(5):505–508.
Lee NS, Dohjima T, Bauer G, et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nature Biotechnol 2002; 20(5):500–505.
Paule MR, White RJ. Survey and summary: transcription by RNA polymerases I and III. Nucleic Acids Res 2000; 28(6):1283–1298.
Zamore PD. RNA interference: listening to the sound of silence. Nature Struct Biol 2001; 8(9): 746–750.
Diallo M, Arenz C, Schmitz K, Sandhoff K, Schepers U. RNA Interference: a new method to analyze the function of glycoproteins and glycosylating proteins in mammalian cells. Knockout experiments with UDP-glucose/ceramide-glucosyltransferase. Methods Enzymol 2003; 363:173–190.
Diallo M, Arenz C, Schmitz K, Sandhoff K, Schepers U. Long endogenous dsRNAs can induce a complete gene silencing in mammalian cells and primary cultures. Oligonucleotides 2003; 13(5):381–392.
Shinagawa T, Ishii S. Generation of Ski-knockdown mice by expressing a long double-strand RNA from an RNA polymerase II promoter. Genes Dev 2003; 17(11):1340–1345.
Lewis DL, Hagstrom JE, Loomis AG, Wolff JA, Herweijer H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nature Genet 2002; 32(1):107–108.
McCaffrey AP, Meuse L, Pham TTT, Conklin DS, Hannon GJ, Kay MA. Gene expression—RNA interference in adult mice. Nature 2002; 418(6893):38–39.
Hemann MT, Fridman JS, Zilfou JT, et al. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nature Genet 2003; 33(3):396–400.
Tiscornia G, Singer O, Ikawa M, Verma IM. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc Natl Acad Sci USA 2003; 100(4):1844–1848.
Rubinson DA, Dillon CP, Kwiatkowski AV, et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nature Genet 2003; 33(3): 401–406.
Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BR. Activation of the interferon system by short-interfering RNAs. Nature Cell Biol 2003; 5(9):834–839.
Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem 1998; 67:227–264.
Bridge AJ, Pebernard S, Ducraux A, Nicoulaz AL, Iggo R. Induction of an interferon response by RNAi vectors in mammalian cells. Nature Genet 2003; 34(3):263–264.
Akusjarvi G, Svensson C, Nygard O. A mechanism by which adenovirus virus-associated RNAI controls translation in a transient expression assay. Mol Cell Biol 1987; 7(1):549–551.
Koopmans M, Duizer E. Foodborne viruses: an emerging problem. Int J Food Microbiol 2004; 90(1): 23–41.
Jacque JM, Triques K, Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature 2002; 418(6896):435–438.
Martinez MA, Clotet B, Este JA. RNA interference of HIV replication. Trends Immunol 2002; 23(12): 559–561.
Yamamoto T, Omoto S, Mizuguchi M, et al. Double-stranded nef RNA interferes with human immunodeficiency virus type 1 replication. Microbiol Immunol 2002; 46(11):809–817.
Anderson J, Banerjea A, Akkina R. Bispecific short hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistance. Oligonucleotides 2003; 13(5):303–312.
Anderson J, Banerjea A, Planelles V, Akkina R. Potent suppression of HIV type 1 infection by a short hairpin anti-CXCR4 siRNA. AIDS Res Hum Retroviruses 2003; 19(8):699–706.
Boden D, Pusch O, Lee F, Tucker L, Shank PR, Ramratnam B. Promoter choice affects the potency of HIV-1 specific RNA interference. Nucleic Acids Res 2003; 31(17):5033–5038.
Pusch O, Boden D, Silbermann R, Lee F, Tucker L, Ramratnam B. Nucleotide sequence homology requirements of HIV-1-specific short hairpin RNA. Nucleic Acids Res 2003; 31(22):6444–6449.
Michienzi A, Castanotto D, Lee N, Li S, Zaia JA, Rossi JJ. RNA-mediated inhibition of HIV in a gene therapy setting. Ann NY Acad Sci 2003; 1002:63–71.
Boden D, Pusch O, Silbermann R, Lee F, Tucker L, Ramratnam B. Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins. Nucleic Acids Res 2004; 32(3):1154–1158.
Dunn SJ, Khan IH, Chan UA, et al. Identification of cell surface targets for HIV-1 therapeutics using genetic screens. Virology 2004; 321(2):260–273.
Novina CD, Murray MF, Dykxhoorn DM, et al. siRNA-directed inhibition of HIV-1 infection. Nature Med 2002; 8(7):681–686.
Andino R. RNAi puts a lid on virus replication. Nature Biotechnol 2003; 21(6):629–630.
Hamasaki K, Nakao K, Matsumoto K, Ichikawa T, Ishikawa H, Eguchi K. Short interfering RNA-directed inhibition of hepatitis B virus replication. FEBS Lett 2003; 543(1–3):51–54.
McCaffrey AP, Meuse L, Karimi M, Contag CH, Kay MA. A potent and specific morpholino antisense inhibitor of hepatitis C translation in mice. Hepatology 2003; 38(2):503–508.
Sen A, Steele R, Ghosh AK, Basu A, Ray R, Ray RB. Inhibition of hepatitis C virus protein expression by RNA interference. Virus Res 2003; 96(1–2):27–35.
Shlomai A, Shaul Y. Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology 2003; 37(4):764–770.
Song E, Lee SK, Wang J, et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nature Med 2003; 9(3):347–351.
Wilson JA, Jayasena S, Khvorova A, et al. RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. Proc Natl Acad Sci USA 2003; 100(5): 2783–2788.
Yokota T, Sakamoto N, Enomoto N, et al. Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO Rep 2003; 4(6):602–608.
Milner J. RNA interference for treating cancers caused by viral infection. Expert Opin Biol Ther 2003; 3(3):459–467.
Butz K, Ristriani T, Hengstermann A, Denk C, Scheffner M, Hoppe-Seyler F. siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene 2003; 22(38): 5938–5945.
Hall AH, Alexander KA. RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells. J Virol 2003; 77(10):6066–6069.
Gitlin L, Karelsky S, Andino R. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 2002; 418(6896):430–434.
Wang QC, Nie QH, Feng ZH. RNA interference: antiviral weapon and beyond. World J Gastroenterol 2003; 9(8):1657–1661.
Godfrey A, Laman H, Boshoff C. RNA interference: a potential tool against Kaposi’s sarcoma-associated herpesvirus. Curr Opin Infect Dis 2003; 16(6):593–600.
Stewart SA, Dykxhoorn DM, Palliser D, et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 2003; 9(4):493–501.
Bitko V, Barik S. Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses. BMC Microbiol 2001; 1(1):34.
Ge Q, McManus MT, Nguyen T, et al. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc Natl Acad Sci USA 2003; 100(5): 2718–2723.
Li XP, Li G, Peng Y, Kung HF, Lin MC. Suppression of Epstein-Barr virus-encoded latent membrane protein-1 by RNA interference inhibits the metastatic potential of nasopharyngeal carcinoma cells. Biochem Biophys Res Commun 2004; 315(1):212–218.
Zhang J, Hua ZC. Targeted gene silencing by small interfering RNA-based knock-down technology. Curr Pharm Biotechnol 2004; 5(1):1–7.
Zhang Y, Li T, Fu L, et al. Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference. FEBS Lett 2004; 560(1–3):141–146.
He ML, Zheng B, Peng Y, et al. Inhibition of SARS-associated coronavirus infection and replication by RNA interference. JAMA 2003; 290(20):2665–2666.
Qin L, Xiong B, Luo C, et al. Identification of probable genomic packaging signal sequence from SARS-CoV genome by bioinformatics analysis. Acta Pharmacol Sin 2003; 24(6):489–496.
Wu HY, Guy JS, Yoo D, Vlasak R, Urbach E, Brian DA. Common RNA replication signals exist among group 2 coronaviruses: evidence for in vivo recombination between animal and human coronavirus molecules. Virology 2003; 315(1):174–183.
McCaffrey AP, Nakai H, Pandey K, et al. Inhibition of hepatitis B virus in mice by RNA interference. Nature Biotechnol 2003; 21(6):639–644.
Lieberman J, Song E, Lee SK, Shankar P. Interfering with disease: opportunities and roadblocks to harnessing RNA interference. Trends Mol Med 2003; 9(9):397–403.
Das AT, Brummelkamp TR, Westerhout EM, et al. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J Virol 2004; 78(5):2601–2605.
Boden D, Pusch O, Lee F, Tucker L, Ramratnam B. Human immunodeficiency virus type 1 escape from RNA interference. J Virol 2003; 77(21):11,531–11,535.
Bastin P, Ellis K, Kohl L, Gull K. Flagellum ontogeny in trypanosomes studied via an inherited and regulated RNA interference system. J Cell Sci 2000; 113(18):3321–3328.
LaCount DJ, Bruse S, Hill KL, Donelson JE. Double-stranded RNA interference in Trypanosoma brucei using head-to-head promoters. Mol Biochem Parasitol 2000; 111(1):67–76.
McRobert L, McConkey GA. RNA interference (RNAi) inhibits growth of Plasmodium falciparum. Mol Biochem Parasitol 2002; 119(2):273–278.
Lillico S, Field MC, Blundell P, Coombs GH, Mottram JC. Essential roles for GPI-anchored proteins in African trypanosomes revealed using mutants deficient in GP18. Mol Biol Cell 2003; 14(3): 1182–1194.
Mohmmed A, Dasaradhi PV, Bhatnagar RK, Chauhan VS, Malhotra P. In vivo gene silencing in Plasmodium berghei—a mouse malaria model. Biochem Biophys Res Commun 2003; 309(3):506–511.
Blackman MJ. RNAi in protozoan parasites: what hope for the Apicomplexa? Protist 2003; 154(2): 177–180.
Ngo H, Tschudi C, Gull K, Ullu E. Double-stranded RNA induces mRNA degradation in Trypanosoma brucei. PNAS 1998; 95(25):14,687–14,692.
Aballay A, Drenkard E, Hilbun LR, Ausubel FM. Caenorhabditis elegans innate immune response triggered by Salmonella enterica requires intact LPS and is mediated by a MAPK signaling pathway. Curr Biol 2003; 13(1):47–52.
Arcus VL, Backbro K, Roos A, Daniel EL, Baker EN. Distant structural homology leads to the functional characterisation of an archaeal PIN-domain as an exonuclease. J Biol Chem 2004; 279:16,471–16,478.
Walduck A, Rudel T, Meyer TF. Proteomic and gene profiling approaches to study host responses to bacterial infection. Curr Opin Microbiol 2004; 7(1):33–38.
Sorensen DR, Leirdal M, Sioud M. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol 2003; 327(4):761–766.
Kelly D, Campbell JI, King TP, et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nature Immunol 2004; 5(1):104–112.
Duxbury MS, Ito H, Benoit E, Zinner MJ, Ashley SW, Whang EE. RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity. Biochem Biophys Res Commun 2003; 311(3):786–792.
Wang Y, Decker SJ, Sebolt-Leopold J. Knockdown of Chk1, Wee1 and Myt1 by RNA interference abrogates G(2) checkpoint and induces apoptosis. Cancer Biol Ther 2004; 3:305–313.
Zangemeister-Wittke U. Antisense to apoptosis inhibitors facilitates chemotherapy and TRAIL-induced death signaling. Ann NY Acad Sci 2003; 1002:90–94.
Chatterjee B. The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer. Mol Cell Biochem 2003; 253(1–2):89–101.
Wall NR, Shi Y. Small RNA: can RNA interference be exploited for therapy? Lancet 2003; 362(9393): 1401–1403.
Brummelkamp TR, Nijman SM, Dirac AM, Bernards R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 2003; 424(6950):797–801.
Tanaka Y, Gavrielides MV, Mitsuuchi Y, Fujii T, Kazanietz MG. Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway. J Biol Chem 2003; 278(36):33,753–33,762.
Milner J. RNA interference for treating cancers caused by viral infection [review]. Expert Opin Biol Ther 2003; 3(3):459–467.
Jiang M, Milner J. Bcl-2 constitutively suppresses p53-dependent apoptosis in colorectal cancer cells. Genes Dev 2003; 17(7):832–837.
Wilda M, Fuchs U, Wossmann W, Borkhardt A. Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene 2002; 21(37):5716–5724.
Lin SL, Chuong CM, Ying SY. A novel mRNA-cDNA interference phenomenon for silencing bcl-2 expression in human LNCaP cells. Biochem Biophys Res Commun 2001; 281(3):639–644.
Chen YG, Lui HM, Lin SL, Lee JM, Ying SY. Regulation of cell proliferation, apoptosis, and carcinogenesis by activin. Exp Biol Med (Maywood) 2002; 227(2):75–87.
Subramanian T, Chinnadurai G. Pro-apoptotic activity of transiently expressed BCL-2 occurs independent of BAX and BAK. J Cell Biochem 2003; 89(6):1102–1114.
Grzmil M, Thelen P, Hemmerlein B, et al. Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells. Am J Pathol 2003; 163(2):543–552.
Dzitoyeva S, Dimitrijevic N, Manev H. Gamma-aminobutyric acid B receptor 1 mediates behavior-impairing actions of alcohol in Drosophila: adult RNA interference and pharmacological evidence. Proc Natl Acad Sci USA 2003; 100(9):5485–5490.
Aza-Blanc P, Cooper CL, Wagner K, Batalov S, Deveraux QL, Cooke MP. Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening. Mol Cell 2003; 12(3):627–637.
Lima RT, Martins LM, Guimaraes JE, Sambade C, Vasconcelos MH. Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells. Cancer Gene Ther 2004; 11:309–316.
Yin JQ, Gao J, Shao R, Tian WN, Wang J, Wan Y. siRNA agents inhibit oncogene expression and attenuate human tumor cell growth. J Exp Ther Oncol 2003; 3(4):194–204.
Konnikova L, Kotecki M, Kruger MM, Cochran BH. Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells. BMC Cancer 2003; 3(1):23.
Sun B, Nishihira J, Suzuki M, et al. Induction of macrophage migration inhibitory factor by lysophosphatidic acid: relevance to tumor growth and angiogenesis. Int J Mol Med 2003; 12(4):633–641.
Liu LT, Chang HC, Chiang LC, Hung WC. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion. Cancer Res 2003; 63(12):3069–3072.
Zhang L, Yang N, Mohamed-Hadley A, Rubin SC, Coukos G. Vector-based RNAi, a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer. Biochem Biophys Res Commun 2003; 303(4): 1169–1178.
Ameri K, Lewis CE, Raida M, Sowter H, Hai T, Harris AL. Anoxic induction of ATF-4 through HIF-1-independent pathways of protein stabilization in human cancer cells. Blood 2004; 103(5):1876–1882.
Niu Q, Perruzzi C, Voskas D, Lawler J, Dumont DJ, Benjamin LE. Inhibition of Tie-2 signaling induces endothelial cell apoptosis, decreases akt signaling, and induces endothelial cell expression of the endogenous anti-angiogenic molecule, thrombospondin-1. Cancer Biol Ther 2004; 3:402–405.
Tien ES, Davis JW, Vanden Heuvel JP. Identification of the CBP/p300 interacting protein CITED2 as a PPARalpha coregulator. J Biol Chem 2004; 279:24,053–24,063.
Zippo A, De Robertis A, Bardelli M, Galvagni F, Oliviero S. Identification of Flk-1-target genes in vasculogenesis: Pim-1 is required for endothelial and mural cell differentiation in vitro. Blood 2004; 103: 4536–4544.
Bachelder RE, Lipscomb EA, Lin X, et al. Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res 2003; 63(17):5230–5233.
Sun Y, Mochizuki Y, Majerus PW. Inositol 1,3,4-trisphosphate 5/6-kinase inhibits tumor necrosis factor-induced apoptosis. J Biol Chem 2003; 278(44):43,645–43,653.
Schafer R, Abraham D, Paulus P, et al. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy. Circulation 2003; 108(13):1585–1591.
Liu Y, Lashuel HA, Choi S, et al. Discovery of inhibitors that elucidate the role of UCH-L1 activity in the H1299 lung cancer cell line. Chem Biol 2003; 10(9):837–846.
Riss D, Jin L, Qian X, et al. Differential expression of galectin-3 in pituitary tumors. Cancer Res 2003; 63(9):2251–2255.
Deroanne C, Vouret-Craviari V, Wang B, Pouyssegur J. EphrinA1 inactivates integrin-mediated vascular smooth muscle cell spreading via the Rac/PAK pathway. J Cell Sci 2003; 116(Pt 7):1367–1376.
Nagashima K, Endo A, Ogita H, et al. Adaptor protein Crk is required for ephrin-B1-induced membrane ruffling and focal complex assembly of human aortic endothelial cells. Mol Biol Cell 2002; 13(12):4231–4242.
Jarad G, Wang B, Khan S, et al. Fas activation induces renal tubular epithelial cell beta 8 integrin expression and function in the absence of apoptosis. J Biol Chem 2002; 277(49):47,826–47,833.
Futami T, Miyagishi M, Seki M, Taira K. Induction of apoptosis in HeLa cells with siRNA expression vector targeted against bcl-2. Nucleic Acids Res Supplement 2002; (Suppl 2):251–252.
Cunningham JM, Weinberg RA. Ras oncogenes in human tumours: identification, mechanism of activation and cooperative role in transformation. IARC Sci Publ 1985(60):359–364.
Duursma AM, Agami R. Ras interference as cancer therapy. Sem Cancer Biol 2003; 13(4):267–273.
Brummelkamp TR, Bernards R, Agami R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2002; 2(3):243–247.
Wolff JA, Herweijer H. Nonviral vectors for cardiovascular gene delivery. Ernst Schering Res Found Workshop 2003(43):41–59.
Lorenz K, Lohse MJ, Quitterer U. Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 2003; 426(6966):574–579.
Maxwell MM, Pasinelli P, Kazantsev AG, Brown RH Jr. RNA interference-mediated silencing of mutant superoxide dismutase rescues cyclosporin A-induced death in cultured neuroblastoma cells. Proc Natl Acad Sci USA 2004; 101(9):3178–3183.
Ding H, Schwarz DS, Keene A, et al. Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. Aging Cell 2003; 2(4):209–217.
Xia XG, Zhou H, Ding H, Affar el B, Shi Y, Xu Z. An enhanced U6 promoter for synthesis of short hairpin RNA. Nucleic Acids Res 2003; 31(17):e100.
Miller VM, Xia H, Marrs GL, et al. Allele-specific silencing of dominant disease genes. Proc Natl Acad Sci USA 2003; 100(12):7195–7200.
Francis R, McGrath G, Zhang J, et al. aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev Cell 2002; 3(1): 85–97.
Asai M, Hattori C, Szabo B, et al. Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase. Biochem Biophys Res Commun 2003; 301(1):231–235.
Mattson MP. Neurobiology: ballads of a protein quartet. Nature 2003; 422(6930):385–387.
Takasugi N, Tomita T, Hayashi I, et al. The role of presenilin cofactors in the gamma-secretase complex. Nature 2003; 422(6930):438–441.
Marlow L, Canet RM, Haugabook SJ, Hardy JA, Lahiri DK, Sambamurti K. APH1, PEN2, and Nicastrin increase Abeta levels and gamma-secretase activity [erratum Biochem Biophys Res Commun 2003 Aug 1; 307(3):756]. Biochem Biophys Res Commun 2003; 305(3):502–509.
Kao SC, Krichevsky AM, Kosik KS, Tsai LH. BACE1 suppression by RNA interference in primary cortical neurons. J Biol Chem 2004; 279(3):1942–1949.
Kiehl TR, Shibata H, Pulst SM. The ortholog of human ataxin-2 is essential for early embryonic patterning in C. elegans. J Mol Neurosci 2000; 15(3):231–241.
Yang Y, Nishimura I, Imai Y, Takahashi R, Lu B. Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila. Neuron 2003; 37(6):911–924.
Love R. First disease model created by RNA interference. Lancet Neurol 2004; 3(1):7.
Trulzsch B, Wood M. Applications of nucleic acid technology in the CNS. J Neurochem 2004; 88(2): 257–265.
Omi K, Tokunaga K, Hohjoh H. Long-lasting RNAi activity in mammalian neurons. FEBS Lett 2004; 558(1–3):89–95.
Trulzsch B, Davies K, Wood M. Survival of motor neuron gene downregulation by RNAi: towards a cell culture model of spinal muscular atrophy. Brain Res Mol Brain Res 2004; 120(2):145–150.
Moon C, Kang WS, Jeong DC, Jin JY. Distribution of adenoviral vector in brain after intravenous administration. J Korean Med Sci 2003; 18(1):108–111.
Xia H, Mao Q, Paulson HL, Davidson BL. siRNA-mediated gene silencing in vitro and in vivo. Nature Biotechnol 2002; 20(10):1006–1010.
Schepers U. Die Wiederentdeckung der RNA. Nachr Chem 2004; 52:302–305.
Wohlbold L, van der Kuip H, Miething C, et al. Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571). Blood 2003; 102(6):2236–2239.
Nieth C, Priebsch A, Stege A, Lage H. Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi). FEBS Lett 2003; 545(2–3):144–150.
Crnkovic-Mertens I, Hoppe-Seyler F, Butz K. Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene. Oncogene 2003; 22(51):8330–8336.
Chen Y, Stamatoyannopoulos G, Song CZ. Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res 2003; 63(16):4801–4804.
Zha S, Ferdinandusse S, Denis S, et al. Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer. Cancer Res 2003; 63(21):7365–7376.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Diallo, M., Schmitz, K., Schepers, U. (2005). RNA Interference. In: LaRochelle, W.J., Shimkets, R.A. (eds) The Oncogenomics Handbook. Cancer Drug Discovery and Development. Humana Press. https://doi.org/10.1385/1-59259-893-5:167
Download citation
DOI: https://doi.org/10.1385/1-59259-893-5:167
Publisher Name: Humana Press
Print ISBN: 978-1-58829-425-8
Online ISBN: 978-1-59259-893-9
eBook Packages: MedicineMedicine (R0)